why choose us

First received: July 28, 2023

Clinical Trial: A Study of TAK-279 in Adults With or Without Liver Damage

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Phase 1 Study to Compare Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of TAK-279 in Subjects With or Without Hepatic Impairment

Brief Summary: The main aim of this study is to find out how the body processes 1 dose of TAK-279 (pharmacokinetics) in participants with liver problems compared to participants without liver problems.Other aims are to check for side effects from TAK-279 and to learn how well participants tolerate 1 dose of TAK-279.The participants will need to stay at the clinic for 11 days.

Read more